Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,373,240
+$5,294,095 QoQ
Shares Held
396,842
+2903.4% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#76
of 626 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 68%
Shared 32%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. OGN ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
This page
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in OGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,373,240 | 396,842 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $79,145 | 13,213 | Shares | Other | 2026-05-15 | |
| 2021-06-30 | $5,795,818 | 191,534 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||